2023. Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study. SKIN The Journal of Cutaneous Medicine. 7, 4 (Jul. 2023), s224. DOI:https://doi.org/10.25251/skin.7.supp.224.